Last update 08 May 2025

QBM-076

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action-
Mechanism-
Therapeutic Areas
Respiratory Diseases
Active Indication-
Inactive Indication
Pulmonary Disease, Chronic Obstructive
Originator Organization
Novartis Pharma AG
Active Organization-
Inactive Organization
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with QBM-076
NCT02890069
/ CompletedPhase 1
Phase Ib, Open-label, Multi-center Study to Characterize the Safety, Tolerability and Pharmacodynamics (PD) of PDR001 in Combination With LCL161, Everolimus (RAD001) or Panobinostat (LBH589)
NCT01972776
/ TerminatedPhase 2
A Two Part, Double Blind, Placebo Controlled, Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Multiple Doses of QBM076 in Patients With COPD
100 Clinical Results associated with QBM-076
Login to view more data
100 Translational Medicine associated with QBM-076
Login to view more data
100 Patents (Medical) associated with QBM-076
Login to view more data
100 Deals associated with QBM-076
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pulmonary Disease, Chronic ObstructivePhase 2
Romania
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
01 Nov 2013
Pulmonary Disease, Chronic ObstructivePhase 2
United Kingdom
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
01 Nov 2013
Pulmonary Disease, Chronic ObstructivePhase 2
Germany
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
01 Nov 2013
Pulmonary Disease, Chronic ObstructivePhase 2
United States
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
01 Nov 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free